Rare Cancer Risk with Breast Implants According to FDA (1.26.11)
After reviewing data on saline and silicone gel breast implants, the FDA has determined that they may be associated with a rare form of cancer called anaplastic large cell lymphoma (ALCL). The cancer tends to form in the scar capsule near the implant.
The FDA is requesting that health care professionals report any confirmed cases of ALCL in women with breast implants.
If you have been diagnosed with ALCL after receiving breast implants then you should:
Complete and submit the report Online: www.fda.gov/MedWatch/report.htm
Download form or call 1-800-332-1088 to request a reporting form, then complete and return to the address on the pre-addressed form, or submit by fax to 1-800-FDA-0178
For further information, go to: Breast Implants: FDA Review Indicates Possible Association With A Rare Cancer